These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Interceptive activity of epostane in pregnant rats and rhesus monkeys].
    Author: Liu CG, Lin ZM, Li WK, Shen PJ, Wang ZX, Bao CY, Xu WX.
    Journal: Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):62-5. PubMed ID: 2403018.
    Abstract:
    A complete interceptive action on pregnancy was shown after ig epostane (Epo) 48 and 96 mg/kg on d 10 of pregnancy in rats. ED50 (95% fiducial limits) of Epo was 20.7 (16.3-26.3) mg/kg. Epo 48 mg/kg ig on d12, 14 and 16 of pregnancy lowered rat plasma progesterone concentrations (P less than 0.05) and plasma corticosterone on d 16 of pregnancy (P less than 0.05). Epo 35 mg/(kg.d) was given ig on d 50-54 of pregnancy in rhesus monkeys. Vaginal bleeding was seen in all of the 6 treated monkeys. Complete expulsions of fetal and placental materials occurred in 5 of the treated monkeys, among which 2 aborted on d 53 and the other 3 on d 54 of pregnancy. Plasma progesterone concentrations of the treated monkeys were lowered on d 52, 53 and 54 of pregnancy (P less than 0.05) and plasma estradiol on d 51, 52, 53, 54 and 55 (P less than 0.05), while there were no significant differences in plasma hydrocortisone. Epo may be a valuable supplement to the existing methods of female contraception.
    [Abstract] [Full Text] [Related] [New Search]